Free Trial

Oscar Health, Inc. (NYSE:OSCR) Shares Sold by First Trust Advisors LP

Oscar Health logo with Finance background

First Trust Advisors LP decreased its holdings in shares of Oscar Health, Inc. (NYSE:OSCR - Free Report) by 47.7% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 290,217 shares of the company's stock after selling 264,999 shares during the quarter. First Trust Advisors LP owned about 0.12% of Oscar Health worth $3,901,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also made changes to their positions in OSCR. 1492 Capital Management LLC purchased a new position in Oscar Health during the fourth quarter worth approximately $440,000. Canada Pension Plan Investment Board increased its holdings in shares of Oscar Health by 510.3% during the 4th quarter. Canada Pension Plan Investment Board now owns 958,200 shares of the company's stock worth $12,878,000 after buying an additional 801,200 shares during the last quarter. Global Endowment Management LP raised its position in shares of Oscar Health by 11.8% in the 4th quarter. Global Endowment Management LP now owns 38,446 shares of the company's stock worth $517,000 after buying an additional 4,045 shares during the period. NewEdge Advisors LLC boosted its holdings in Oscar Health by 9,811.2% in the fourth quarter. NewEdge Advisors LLC now owns 99,112 shares of the company's stock valued at $1,332,000 after acquiring an additional 98,112 shares during the last quarter. Finally, Jump Financial LLC grew its position in Oscar Health by 57.4% during the fourth quarter. Jump Financial LLC now owns 562,376 shares of the company's stock valued at $7,558,000 after acquiring an additional 204,985 shares during the period. Hedge funds and other institutional investors own 75.70% of the company's stock.

Analyst Upgrades and Downgrades

Separately, Wells Fargo & Company downgraded Oscar Health from an "overweight" rating to an "equal weight" rating and cut their price objective for the stock from $20.00 to $16.00 in a report on Thursday, March 13th. Two analysts have rated the stock with a sell rating, three have given a hold rating, two have issued a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, Oscar Health currently has a consensus rating of "Hold" and a consensus target price of $20.21.

View Our Latest Report on OSCR

Oscar Health Stock Up 0.8 %

Shares of NYSE OSCR traded up $0.11 on Tuesday, hitting $13.11. The company had a trading volume of 6,908,626 shares, compared to its average volume of 3,937,997. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.26. Oscar Health, Inc. has a 12-month low of $11.20 and a 12-month high of $23.79. The firm has a market capitalization of $3.28 billion, a P/E ratio of -654.92 and a beta of 1.75. The business has a 50 day moving average of $13.25 and a two-hundred day moving average of $14.62.

Oscar Health (NYSE:OSCR - Get Free Report) last released its quarterly earnings results on Tuesday, February 4th. The company reported ($0.62) earnings per share for the quarter, missing analysts' consensus estimates of ($0.55) by ($0.07). Oscar Health had a return on equity of 2.28% and a net margin of 0.28%. As a group, equities research analysts forecast that Oscar Health, Inc. will post 0.69 earnings per share for the current fiscal year.

Oscar Health Profile

(Free Report)

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.

Featured Stories

Institutional Ownership by Quarter for Oscar Health (NYSE:OSCR)

Should You Invest $1,000 in Oscar Health Right Now?

Before you consider Oscar Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oscar Health wasn't on the list.

While Oscar Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Palantir’s Big Moves: Profit-Taking, Price Targets & AI Potential
Buy Early: 3 Tech Trends With Millionaire-Making Potential
SMCI Stumbles on Earnings: Why Some Investors Still Want In

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines